BioScience Health Innovations's quarterly market cap
stayed the same
from Sep. 2025 ($43.92 Mil) to Dec. 2025 ($43.92 Mil) but then
declined
from Dec. 2025 ($43.92 Mil) to Mar. 2026 ($24.09 Mil).
BioScience Health Innovations's annual market cap
increased
from Dec. 2023 ($531.65 Mil) to Dec. 2024 ($570.91 Mil) but then
declined
from Dec. 2024 ($570.91 Mil) to Dec. 2025 ($43.92 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. BioScience Health Innovations's Enterprise Value for Today is $48.74 Mil.
BioScience Health Innovations (OTCPK:BHIC) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
BioScience Health Innovations Market Cap Related Terms
BioScience Health Innovations Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, BioScience Health Innovations's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioScience Health Innovations Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, BioScience Health Innovations's Market Cap distribution charts can be found below:
* The bar in red indicates where BioScience Health Innovations's Market Cap falls into.
BioScience Health Innovations Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioScience Health Innovations (BHIC) has a Market Cap of $49.42 Mil as of Jun. 28, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on BioScience Health Innovations and its competitors. According to the industry distribution chart, BioScience Health Innovations ranks #425 out of 694 companies in the Healthcare Providers & Services industry, placing it in the top 61.2%.
Is BioScience Health Innovations' Market Cap too high?
BioScience Health Innovations' current Market Cap is $49.42 Mil. The Healthcare Providers & Services industry median Market Cap is 92.82. BioScience Health Innovations' value of $49.42 Mil is 46.8% below this industry median. Based on the distribution chart, BioScience Health Innovations ranks #425 out of 694 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, BioScience Health Innovations has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BioScience Health Innovations' Market Cap compare to PETS and SHFH?
According to the Healthcare Providers & Services industry distribution chart, BioScience Health Innovations ranks #425 out of 694 companies for Market Cap. This places BioScience Health Innovations in the lower half of its industry. The industry median Market Cap is 92.82. BioScience Health Innovations' value of $49.42 Mil is 46.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 92.82, based on 694 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioScience Health Innovations's current Market Cap of $49.42 Mil is 46.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on BioScience Health Innovations and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 92.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioScience Health Innovations's current Market Cap is $49.42 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioScience Health Innovations stock overvalued right now?
Based on GuruFocus' analysis, BioScience Health Innovations (BHIC) is currently considered Possible Value Trap. The stock's GF Value™ is $164.84, compared to a current price of $4.33 — trading 97.4% below its estimated fair value. The current Market Cap is $49.42 Mil and 46.8% below the Healthcare Providers & Services industry median of 92.82. BioScience Health Innovations' overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For BioScience Health Innovations (BHIC), the current Market Cap is $49.42 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BioScience Health Innovations (BHIC) Overvalued in 2026?
Based on GuruFocus' analysis, BioScience Health Innovations stock appears to be undervalued.
The current stock price of $4.33 is trading 97.4% below its estimated GF Value™ of $164.84.
GuruFocus considers BioScience Health Innovations to be Possible Value Trap.
Key valuation signals for BHIC:
Market Cap: $49.42 Mil
GF Value™: $164.84 vs. price of $4.33 (97.4% below fair value)
Industry Position: 46.8% below the Healthcare Providers & Services median (#425 of 694)
No single metric tells the full story. See the BHIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BioScience Health Innovations Business Description
BioScience Health Innovations Inc is engaged in full-scale operations as a distributor and generates revenue. The company's main business is to sell clinically tested, affordably priced products to naturally battle the onslaught of bacteria and viruses through online sales and various other distribution channels. The company develops, manufactures, and distributes science-backed nutritional supplements and delivery systems targeting cellular health, mitochondrial optimization, hormonal balance, and longevity.
47GF Score
Get the complete analysis for BHIC
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BHIC has been successfully added to your 
